New CRISPR advance delivers a one-two punch to lung cancer cells

July 6, 2020

A mutation unique to certain cancer tumors is a potential homing beacon for safely deploying CRISPR gene editing enzymes to disarm DNA that makes cancer cells resistant to treatment, while ignoring the gene in normal cells where it’s critical to healthy function. Read more